SCHEMBL18320640

SCHEMBL18320640

NC(=O)c1ccnc2oncc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
SLC40A1 Q9NP59 2/20 0.36
SIRT3 Q9NTG7 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
PARP1 P09874 1/20 0.34
PIK3CB P42338 1/20 0.34
HTT P42858 1/20 0.33
MAP2K1 Q02750 1/20 0.33
CLK4 Q9HAZ1 1/20 0.33
DYRK1B Q9Y463 1/20 0.33
NUDT1 P36639 1/20 0.33
CDC7 O00311 1/20 0.33
KMT2A Q03164 1/20 0.33
ATM Q13315 1/20 0.33
GRM5 P41594 1/20 0.32
ALDH1A1 P00352 2/20 0.32
MKNK1 Q9BUB5 1/20 0.32
MKNK2 Q9HBH9 1/20 0.32
HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL458978 0.84 KDM4E (0.44) KDM4EL3MBTL1TDP1KMT2AALDH1A1
SCHEMBL2003887 0.70 ALDH1A1 (0.44) KDM4EL3MBTL1PARP1MAP2K1CLK4
SCHEMBL13043597 0.68 CCR1 (0.45) L3MBTL1
SCHEMBL5799150 0.67 KDM4E (0.49) KDM4EL3MBTL1SLC40A1SIRT3TDP1
SCHEMBL3577315 0.67 KDM4E (0.53) KDM4EL3MBTL1SIRT3TDP1HTT
SCHEMBL607663 0.66 KDM4E (0.57) KDM4EL3MBTL1SLC40A1HTTKMT2A
SCHEMBL2414115 0.66 KDM4E (0.57) KDM4EL3MBTL1SLC40A1PARP1HTT
SCHEMBL30688511 0.66 KDM4E (0.57) KDM4EL3MBTL1SLC40A1PARP1HTT
SCHEMBL29381262 0.66 KDM4E (0.57) KDM4EL3MBTL1SLC40A1HTTKMT2A
SCHEMBL1694892 0.66 RET (0.46) KDM4EL3MBTL1SLC40A1SIRT3TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016202898-A1 GLUCOSE TRANSPORT INHIBITORS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2016-12-22 WO claimed
WO-2016202898-A1 GLUCOSE TRANSPORT INHIBITORS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2016-12-22 WO disclosed